Results 311 to 320 of about 419,079 (384)
Some of the next articles are maybe not open access.
Clinics in Liver Disease, 2004
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Emmet B. Keeffe +3 more
openaire +6 more sources
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Emmet B. Keeffe +3 more
openaire +6 more sources
Science Translational Medicine, 2020
Hepatitis B vaccines formulated with different adjuvants induce a consistent core inflammatory signature linked to vaccine immunogenicity. Patterns of adjuvanticity Understanding how adjuvants improve vaccine-induced immune responses is important for the
Laurane de Mot +13 more
semanticscholar +1 more source
Hepatitis B vaccines formulated with different adjuvants induce a consistent core inflammatory signature linked to vaccine immunogenicity. Patterns of adjuvanticity Understanding how adjuvants improve vaccine-induced immune responses is important for the
Laurane de Mot +13 more
semanticscholar +1 more source
Nature, 1976 The high rate of infection with hepatitis B virus in certain defined populations in industralized countries and among the general population in many non-industrialized countries stresses the need for hepatitis B vaccines. Hepatitis B, one of at least six different forms of viral hepatitis, may progress to chronic liver disease, including chronic ...
openaire +3 more sources
Journal of Virological Methods, 1985
As hepatitis B virus does not replicate in tissue culture systems, it was impossible to prepare a vaccine in the conventional way. However, the surface-antigen of the virus is present in abundance in the blood of certain virus carriers. This phenomenon has been used to develop plasma-derived hepatitis B vaccines and these vaccines are now available. In
openaire +6 more sources
As hepatitis B virus does not replicate in tissue culture systems, it was impossible to prepare a vaccine in the conventional way. However, the surface-antigen of the virus is present in abundance in the blood of certain virus carriers. This phenomenon has been used to develop plasma-derived hepatitis B vaccines and these vaccines are now available. In
openaire +6 more sources
Hepatitis B Vaccines in Clinical Practice
, 1992Interestingly, hepatitis b vaccines in clinical practice that you really wait for now is coming. It's significant to wait for the representative and beneficial books to read.
R. Ellis
semanticscholar +1 more source
Vaccine, 2003
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +4 more sources
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +4 more sources